(Q34542736)

2 August 2017

1 reference

title

Acute-on-chronic Liver Failure (English)

1 reference

2 August 2017

1 reference

1

Shiv Kumar Sarin

1 reference

2 August 2017

Ashok Choudhury

2

1 reference

2 August 2017

publication date

1 December 2016

1 reference

Current gastroenterology reports

2 August 2017

published in

1 reference

2 August 2017

volume

18

1 reference

2 August 2017

issue

12

1 reference

2 August 2017

page(s)

61

1 reference

Acute-on-chronic liver failure: consensus recommendations of the Asian Pacific Association for the Study of the Liver (APASL) 2014.

2 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS11894-016-0535-8

Lessons from look-back in acute liver failure? A single centre experience of 3300 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-016-0535-8

Acute-on-Chronic Liver Failure Is a Distinct Syndrome That Develops in Patients With Acute Decompensation of Cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-016-0535-8

Keeping high model for end-stage liver disease score liver transplantation candidates alive

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-016-0535-8

Acute-on-chronic liver failure: terminology, mechanisms and management

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-016-0535-8

The CLIF Consortium Acute Decompensation score (CLIF-C ADs) for prognosis of hospitalised cirrhotic patients without acute-on-chronic liver failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-016-0535-8

Acute-on-chronic liver failure: current concepts on definition, pathogenesis, clinical manifestations and potential therapeutic interventions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-016-0535-8

Patients with Diabetes Mellitus are Prone to Develop Severe Hepatitis and Liver Failure due to Hepatitis Virus Infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-016-0535-8

Hepatitis E virus (HEV) infection in patients with cirrhosis is associated with rapid decompensation and death

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-016-0535-8

Is hepatitis E virus an emerging problem in industrialized countries?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-016-0535-8

Hepatitis E virus as an etiology of acute exacerbation of previously unrecognized asymptomatic patients with hepatitis B virus-related chronic liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-016-0535-8

Acute hepatitis A and B in patients with chronic liver disease: prevention through vaccination

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-016-0535-8

Comparison of effects of hepatitis E or A viral superinfection in patients with chronic hepatitis B

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-016-0535-8

Hepatic and systemic hemodynamic derangements predict early mortality and recovery in patients with acute-on-chronic liver failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-016-0535-8

Risk factors and outcome of bacterial infections in cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-016-0535-8

Cirrhosis-associated immune dysfunction: distinctive features and clinical relevance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-016-0535-8

Altered frequencies of dendritic cells and IFN-gamma-secreting T cells with granulocyte colony-stimulating factor (G-CSF) therapy in acute-on- chronic liver failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-016-0535-8

Stress, inflammation, and defense of homeostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-016-0535-8

Systemic inflammatory response and serum lipopolysaccharide levels predict multiple organ failure and death in alcoholic hepatitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-016-0535-8

Role of cytokines in the pathophysiology of acute-on-chronic liver failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-016-0535-8

M2 Kupffer cells promote M1 Kupffer cell apoptosis: a protective mechanism against alcoholic and nonalcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-016-0535-8

Pro-inflammatory cytokines tumor necrosis factor alpha and interleukin-6 and survival factor epidermal growth factor positively regulate the murine GSTA4 enzyme in hepatocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-016-0535-8

Cellular localization of endothelin-1 and increased production in liver injury in the rat: potential for autocrine and paracrine effects on stellate cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-016-0535-8

Intraperitoneal LPS amplifies portal hypertension in rat liver fibrosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-016-0535-8

Neutrophil dysfunction in alcoholic hepatitis superimposed on cirrhosis is reversible and predicts the outcome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-016-0535-8

Patients with acute-on-chronic liver failure have increased numbers of regulatory immune cells expressing the receptor tyrosine kinase MERTK.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-016-0535-8

Increased MerTK expression in circulating innate immune cells of patients with septic shock.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-016-0535-8

Bacterial DNA translocation is associated with systemic circulatory abnormalities and intrahepatic endothelial dysfunction in patients with cirrhosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-016-0535-8

Acute-on-chronic liver failure in cirrhosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-016-0535-8

Model for end-stage liver disease score and systemic inflammatory response are major prognostic factors in patients with cirrhosis and acute functional renal failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-016-0535-8

SIRS at Admission Is a Predictor of AKI Development and Mortality in Hospitalized Patients with Severe Alcoholic Hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-016-0535-8

Liver transplantation for acute-on-chronic liver failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-016-0535-8

Corticosteroids improve short-term survival in patients with severe alcoholic hepatitis: meta-analysis of individual patient data

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-016-0535-8

Prognosis of acute severe autoimmune hepatitis (AS-AIH): the role of corticosteroids in modifying outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-016-0535-8

Early predictors of corticosteroid treatment failure in icteric presentations of autoimmune hepatitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-016-0535-8

A histologic scoring system for prognosis of patients with alcoholic hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-016-0535-8

Effect of a carbohydrate-containing late-evening snack on energy metabolism and fasting substrate utilization in adults with acute-on-chronic liver failure due to Hepatitis B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-016-0535-8

Evaluation of acute kidney injury and its response to terlipressin in patients with acute-on-chronic liver failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-016-0535-8

Experience of combined liver-kidney transplantation for acute-on-chronic liver failure patients with renal dysfunction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-016-0535-8

Infection in patients with severe alcoholic hepatitis treated with steroids: early response to therapy is the key factor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-016-0535-8

Acute-on-chronic liver failure: excellent outcomes after liver transplantation but high mortality on the wait list

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-016-0535-8

Impacts of pretransplant infections on clinical outcomes of patients with acute-on-chronic liver failure who received living-donor liver transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-016-0535-8

Live-donor liver transplantation for acute-on-chronic hepatitis B liver failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-016-0535-8

Retracted: Downgrading MELD Improves the Outcomes after Liver Transplantation in Patients with Acute-on-Chronic Hepatitis B Liver Failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-016-0535-8

Impact of pretransplant MELD score on posttransplant outcome in orthotopic liver transplantation for patients with acute-on-chronic hepatitis B liver failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-016-0535-8

Liver transplantation in acute on chronic liver failure: challenges and an algorithm for patient selection and management.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-016-0535-8

Early liver transplantation for severe alcoholic hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-016-0535-8

Clinical Course of acute-on-chronic liver failure syndrome and effects on prognosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-016-0535-8

Effects of fractionated plasma separation and adsorption on survival in patients with acute-on-chronic liver failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-016-0535-8

Extracorporeal albumin dialysis with the molecular adsorbent recirculating system in acute-on-chronic liver failure: the RELIEF trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-016-0535-8

Molecular adsorbent recirculating system as artificial support therapy for liver failure: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-016-0535-8

Hemodiabsorption in treatment of acute hepatic failure and chronic cirrhosis with ascites

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-016-0535-8

Pathophysiological effects of albumin dialysis in acute-on-chronic liver failure: a randomized controlled study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-016-0535-8

Effect of the molecular adsorbent recirculating system and Prometheus devices on systemic haemodynamics and vasoactive agents in patients with acute-on-chronic alcoholic liver failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-016-0535-8

Systematic review and meta-analysis of survival following extracorporeal liver support.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-016-0535-8

Stem cell therapies for liver failure and cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-016-0535-8

Human hepatocyte transplantation: current experience and future challenges.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-016-0535-8

Cell therapy for liver disease: From liver transplantation to cell factory

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-016-0535-8

Autologous bone marrow mononuclear cell transplantation in patients with decompensated alcoholic liver disease: a randomized controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-016-0535-8

Granulocyte-colony stimulating factor therapy improves survival in patients with hepatitis B virus-associated acute-on-chronic liver failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-016-0535-8

Combination of granulocyte colony-stimulating factor and erythropoietin improves outcomes of patients with decompensated cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-016-0535-8

Role of stem cell factor and granulocyte colony-stimulating factor in remodeling during liver regeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-016-0535-8

Update on clinical experience with AMD3100, an SDF-1/CXCL12-CXCR4 inhibitor, in mobilization of hematopoietic stem and progenitor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-016-0535-8

Recombinant human hepatocyte growth factor for liver failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-016-0535-8

A case of granulocyte-colony stimulating factor/plasmapheresis-induced activation of granulocyte-colony stimulating factor-positive hepatic progenitors in acute-on-chronic liver failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-016-0535-8

Management of patients with hepatitis B who require immunosuppressive therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-016-0535-8

Gut-liver axis in liver cirrhosis: How to manage leaky gut and endotoxemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-016-0535-8

Diagnosis, management and prevention of drug-induced liver injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-016-0535-8

Difference in T helper responses during hepatitis flares in hepatitis B e antigen (HBeAg)-positive patients with genotypes B and C: implication for early HBeAg seroconversion

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-016-0535-8

Granulocyte colony-stimulating factor in severe alcoholic hepatitis: a randomized pilot study

21 January 2018

1 reference

12 December 2020

Liver transplantation in acute-on-chronic liver failure patients with high model for end-stage liver disease (MELD) scores: a single center experience of 100 consecutive cases

1 reference

12 December 2020

In vitro steroid resistance correlates with outcome in severe alcoholic hepatitis

1 reference

12 December 2020

Acute-on-chronic liver failure before liver transplantation: impact on posttransplant outcomes

1 reference

12 December 2020

Alcoholic liver disease: mechanisms of injury and targeted treatment

1 reference

12 December 2020

Monitoring of intrasplenic hepatocyte transplantation for acute-on-chronic liver failure: a prospective five-year follow-up study

1 reference

12 December 2020

Liver dialysis in acute-on-chronic liver failure: current and future perspectives.

1 reference

12 December 2020

Tenofovir improves the outcome in patients with spontaneous reactivation of hepatitis B presenting as acute-on-chronic liver failure

1 reference

12 December 2020

Artificial and bioartificial liver support systems for acute and acute-on-chronic hepatic failure: A meta-analysis and meta-regression

1 reference

12 December 2020

Therapeutic effect of autologous bone marrow-derived liver stem cells transplantation in hepatitis B virus-induced liver cirrhosis

1 reference

12 December 2020

Prospective, randomized, multicenter, controlled trial of a bioartificial liver in treating acute liver failure.

1 reference

12 December 2020

Defining acute-on-chronic liver failure: will East and West ever meet?

1 reference

12 December 2020

Infection and inflammation in liver failure: two sides of the same coin

1 reference

12 December 2020

Autologous transplantation of bone marrow-derived mononuclear and CD133(+) cells in patients with decompensated cirrhosis.

1 reference

12 December 2020

Severity of the compensatory anti-inflammatory response determined by monocyte HLA-DR expression may assist outcome prediction in cirrhosis

1 reference

12 December 2020

Granulocyte colony-stimulating factor mobilizes CD34(+) cells and improves survival of patients with acute-on-chronic liver failure

1 reference

12 December 2020

Liver histology as predictor of outcome in patients with acute-on-chronic liver failure (ACLF).

1 reference

12 December 2020

Safety and efficacy profile of G-CSF therapy in patients with acute on chronic liver failure

1 reference

12 December 2020

Toll-like receptor (TLR) 2 promoter and intron 2 polymorphisms are associated with increased risk for spontaneous bacterial peritonitis in liver cirrhosis

1 reference

12 December 2020

Dual effect of erythropoietin on liver protection and regeneration after subtotal hepatectomy in rats

1 reference

12 December 2020

Patients with acute on chronic liver failure display "sepsis-like" immune paralysis

1 reference

12 December 2020

Altered immune function of monocytes in different stages of patients with acute on chronic liver failure.

1 reference

12 December 2020

Clinical profile and predictors of mortality in patients of acute-on-chronic liver failure

1 reference

12 December 2020

Simple organ failure count versus CANONIC grading system for predicting mortality in acute-on-chronic liver failure

1 reference

12 December 2020

10.1007/S11894-016-0535-8

Identifiers

DOI

1 reference

Dimensions Publication ID

2 August 2017

1003673272

0 references

1 reference